ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ANO10 | Anoctamin 10 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ARIH2OS | Ariadne homolog 2 opposite strand | Predicted membrane proteins
| | | | | Mixed |
ARSE | Arylsulfatase E (chondrodysplasia punctata 1) | Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARSF | Arylsulfatase F | Predicted membrane proteins
| | | | | Group enriched |
ARSH | Arylsulfatase family, member H | Predicted membrane proteins
| | | | | Not detected |
ASIC1 | Acid-sensing (proton-gated) ion channel 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ASIC2 | Acid-sensing (proton-gated) ion channel 2 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ASIC3 | Acid-sensing (proton-gated) ion channel 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
ASIC4 | Acid-sensing (proton-gated) ion channel family member 4 | Predicted membrane proteins
| | | | | Tissue enriched |
ASIC5 | Acid-sensing (proton-gated) ion channel family member 5 | Predicted membrane proteins
| | | | | Group enriched |
ASTN1 | Astrotactin 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ASTN2 | Astrotactin 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATG9A | Autophagy related 9A | Predicted membrane proteins
| | | | | Expressed in all |
ATL1 | Atlastin GTPase 1 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATL2 | Atlastin GTPase 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATL3 | Atlastin GTPase 3 | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP11A | ATPase, class VI, type 11A | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP11B | ATPase, class VI, type 11B | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP13A2 | ATPase type 13A2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP13A3 | ATPase type 13A3 | Predicted membrane proteins
| | | | | Expressed in all |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATP2A3 | ATPase, Ca++ transporting, ubiquitous | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP5F1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP5G1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP5G2 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP6V0B | ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b | Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0E1 | ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 | Predicted membrane proteins
| | | | | Expressed in all |
ATP6V0E2 | ATPase, H+ transporting V0 subunit e2 | Predicted membrane proteins
| | | | | Expressed in all |
ATP8B3 | ATPase, aminophospholipid transporter, class I, type 8B, member 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ATRAID | All-trans retinoic acid-induced differentiation factor | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRN | Attractin | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRNL1 | Attractin-like 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AUP1 | Ancient ubiquitous protein 1 | Predicted membrane proteins
| | | | | Expressed in all |
AWAT2 | Acyl-CoA wax alcohol acyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
BAI3 | Brain-specific angiogenesis inhibitor 3 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
BAK1 | BCL2-antagonist/killer 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
BANP | BTG3 associated nuclear protein | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BCAP29 | B-cell receptor-associated protein 29 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
BCL2 | B-cell CLL/lymphoma 2 | Cancer-related genes Disease related genes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BCL2L2 | BCL2-like 2 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |